Tested Applications
| Positive WB detected in | LNCaP cells, MCF-7 cells, mouse colon tissue, rat colon tissue |
| Positive IHC detected in | human colon tissue, human stomach tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunohistochemistry (IHC) | IHC : 1:100-1:400 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
27176-1-AP targets ST14 in WB, IHC, IF, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag26007 Product name: Recombinant human ST14 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 301-539 aa of BC030532 Sequence: YNLTFHSSQNVLLITLITNTERRHPGFEATFFQLPRMSSCGGRLRKAQGTFNSPYYPGHYPPNIDCTWNIEVPNNQHVKVRFKFFYLLEPGVPAGTCPKDYVEINGEKYCGERSQFVVTSNSNKITVRFHSDQSYTDTGFLAEYLSYDSSDPCPGQFTCRTGRCIRKELRCDGWADCTDHSDELNCSCDAGHQFTCKNKFCKPLFWVCDSVNDCGDNSDEQGCSCPAQTFRCSNGKCLS Predict reactive species |
| Full Name | suppression of tumorigenicity 14 (colon carcinoma) |
| Calculated Molecular Weight | 94.7 kDa |
| Observed Molecular Weight | 100 kDa |
| GenBank Accession Number | BC030532 |
| Gene Symbol | ST14 |
| Gene ID (NCBI) | 6768 |
| RRID | AB_2880788 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9Y5Y6 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Suppression of tumorigenicity 14(ST14), is an epithelial-derived, integral membrane serine protease. ST14 forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. ST14 can cleave and activate hepatocyte growth factor/scattering factor, and uPA, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for ST14 antibody 27176-1-AP | Download protocol |
| WB protocol for ST14 antibody 27176-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ST14 Polyclonal antibody (Cat# 27176-1-AP) has 1 total citation. It was cited in BMC Cancer (IF 4.1), a 2024 study by Xin Nie et al. investigating ST14's interaction with TMEFF1 as a predictor of poor prognosis in ovarian cancer. The research field is oncology, specifically ovarian cancer prognosis and biomarker discovery. The antibody was applied in WB, IHC, IF, and CoIP in human samples.
| Species | Application | Title |
|---|---|---|
BMC Cancer ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer |













